Expression of Fcγ receptors on MO/MA and LPS-activated MDM
Fcγ receptor . | Culture period . | ND PB . | . | EOC PB . | . | EOC ascites . | . | |||
---|---|---|---|---|---|---|---|---|---|---|
. | . | CD14+ . | CD14brightCD16−HLA-DR+ . | CD14+ . | CD14brightCD16−HLA-DR+ . | CD14+ . | CD14brightCD16−HLA-DR+ . | |||
CD16 | 1 h | + | + | ++ | ++++ | + | + | |||
8 d | + | − | − | − | − | − | ||||
CD64 | 1 h | ++++ | ++++ | ++++ | ++++ | ++++ | ++++ | |||
8 d | ++++ | ++++ | − | − | ++ | − | ||||
CD32 | 1 h | ++++ | ++++ | ++++ | ++++ | ++++ | +++ | |||
8 d | ++++ | ++++ | + | + | ++ | + | ||||
CD32B | 1 h | + | + | ++++ | +++ | +++ | ++++ | |||
8 d | ++++ | ++++ | + | + | ++ | ++ |
Fcγ receptor . | Culture period . | ND PB . | . | EOC PB . | . | EOC ascites . | . | |||
---|---|---|---|---|---|---|---|---|---|---|
. | . | CD14+ . | CD14brightCD16−HLA-DR+ . | CD14+ . | CD14brightCD16−HLA-DR+ . | CD14+ . | CD14brightCD16−HLA-DR+ . | |||
CD16 | 1 h | + | + | ++ | ++++ | + | + | |||
8 d | + | − | − | − | − | − | ||||
CD64 | 1 h | ++++ | ++++ | ++++ | ++++ | ++++ | ++++ | |||
8 d | ++++ | ++++ | − | − | ++ | − | ||||
CD32 | 1 h | ++++ | ++++ | ++++ | ++++ | ++++ | +++ | |||
8 d | ++++ | ++++ | + | + | ++ | + | ||||
CD32B | 1 h | + | + | ++++ | +++ | +++ | ++++ | |||
8 d | ++++ | ++++ | + | + | ++ | ++ |
NOTE: −, no positive cells; +, <10% positive; ++, 10% to 50% positive; +++, 50% to 75% positive; ++++, >75% positive.